| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.5B | $17.3B | $14.6B | $12.1B | $11.9B | $9.6B | $8.2B | $7.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.6B | $1.4B | $2.5B | $0.6B | $1.4B | $0.1B | $0.2B | $-0.4B |
| EPS (Basic) | $37.80 | $31.78 | $60.19 | $15.19 | $34.66 | $1.59 | $5.34 | $-9.50 |
| EPS (Diluted) | $37.80 | $31.78 | $60.19 | $15.19 | $34.62 | $1.59 | $5.32 | $-9.50 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $62.5B | $56.3B | $49.4B | $40.0B | $38.2B | $32.8B | $27.3B | $24.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.3B | $1.5B | $1.4B | $1.4B | $1.4B | $0.8B | $0.8B | $0.7B |
| Total Liabilities | $47.1B | $42.5B | $36.2B | $31.5B | $28.0B | $23.1B | $18.2B | $16.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $15.5B | $13.9B | $13.2B | $8.4B | $10.1B | $9.7B | $9.1B | $7.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.1B | $5.0B | $4.6B | $3.7B | $3.8B | $2.9B | $1.9B | $0.6B |
| Investing Cash Flow | $-2.1B | $-4.5B | $-5.9B | $-3.4B | $-3.9B | $-3.7B | $-1.4B | $-0.3B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.2B | $-0.4B | $1.4B | $-0.4B | $0.7B | $0.8B | $-0.3B | $-0.3B |